Predictive Oncology Inc. company info

CIK 1446159
IRS Number 331007393
State of incorporation DE
Business address 2915 COMMERS DRIVE,
Mail address 2915 COMMERS DRIVE,

Short summary

Predictive Oncology Inc. is a Minnesota company, with head office located at 2915 Commers Drive, Eagan, Minnesota 55121. In 2019 the company owned a total of 25.05 million USD worth of assets, including 3.74 million USD worth of current assets. 2018 was the year when the company amassed the most assets.

Predictive Oncology Inc. Income Statement

Name [in Millions USD]2001200220032004200520062007200820092010201120122013201420152016201720182019Trends
Cost of Goods and Services Sold
Gross Profit
Research and development 0.100.0100.020.240.390.260.410.290.530.42
Operating Expenses 6.057.86
Operating Income (Loss) -7.86-13.77
Interest expense
Income Tax Expense (Benefit) 0000
Net income -1.35-4.49-7.42-9.41-6.83-10.09-19.39

Predictive Oncology Inc. Balance Sheet

Name [in Millions USD]2001200220032004200520062007200820092010201120122013201420152016201720182019Trends
Cash and cash equivalents 00.460.
Accounts Receivable, Net, Current
Property, Plant and Equipment, Gross
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Goodwill 23.7915.69
Intangible Assets, Net (Excluding Goodwill)
Total assets
Current assets
Accounts payable 0.810.730.660.661.632.470.750.060.173.543.13
Total current liabilities 0.481.431.922.453.393.916.891.551.260.939.4612.37
Long-term Debt, Excluding Current Maturities 0.130.660.0900
Total liabilities 3.674.206.892.111.330.649.9614.69
Common Stock, Value, Issued
Retained Earnings (Accumulated Deficit) 0.01-35.64-45.23-50.90-58.90-64.94-87.03
Accumulated Other Comprehensive Income (Loss), Net of Tax 0.01

Predictive Oncology Inc. Cash Flow

Name [in Millions USD]2001200220032004200520062007200820092010201120122013201420152016201720182019Trends
Net income -1.35-4.49-7.42-9.41-6.83-10.09-19.39
Depreciation and amortization 0.70
Amortization of Intangible Assets
Depreciation and amortization
Accounts receivable 0.02-0.020.05-0.010.06-0.04-
Inventories 00.100.05-0.020.25-0.140.04-0.01-0.02-0.09
Accounts payable 1.13-1.54-0.43-0.080.310.37
Deferred revenue 00.07-0.060.00-0.00
Net Cash Provided by (Used in) Operating Activities -1.31-0.82-1.78-1.18-4.38-4.46-5.29-8.73
Payments to Acquire Property, Plant, and Equipment 00000.
Payments to Acquire Intangible Assets 00000.
Net Cash Provided by (Used in) Investing Activities 0000-0.42-1.65-1.11-0.60
Net Cash Provided by (Used in) Investing Activities, Continuing Operations 0-0.22-0.12-0.06-0.42
Proceeds from Issuance of Long-term Debt 0.100.600.530.531.821.50
Proceeds from Issuance of Common Stock 0.630.221.390.702.340.1613.051.713.812.965.32
Payments for Repurchase of Common Stock -0.170
Net Cash Provided by (Used in) Financing Activities 0.860.811.901.071.715.115.799.32
Cash and Cash Equivalents, Period Increase (Decrease) -0.45-0.010.11-0.110.09-0.09-3.09-1.00